Pharma Reviews
Pages
(Move to ...)
Home
Pharma News
US FDA News
Pharma Jobs
▼
Friday, March 24, 2017
US FDA News: HeartStart MRx Monitor/Defibrillator by Phillips Healthcare: Class I Recall - Electrical Issues
A delay in delivering therapy could result in serious patient injury such as permanent organ damage, brain injury, or death.
Read more:
HeartStart MRx Monitor/Defibrillator by Phillips Healthcare: Class I Recall - Electrical Issues
‹
›
Home
View web version